Tanya R. Syffrard

FDA investigator

Appears on 11 documents from 2021 to 2025, mostly at sites in New York. Most often cites stability testing (21 CFR 211.166).

11
Documents on file
5.9
Observations per 483
2021
First seen
2025
Most recent

What they cite most

From 62 observations

Activity by year

2021: 2, 2022: 3, 2023: 1, 2024: 3, 2025: 2

Where

New York 6 · New Jersey 2 · New Hampshire 1 · Pennsylvania 1 · South Carolina 1

Is Tanya R. Syffrard coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 AAA Pharmaceutical, Inc.Mar 28, 2025 · Lumberton, New Jersey
483 Bausch & Lomb IncorporatedFeb 27, 2025 · Greenville, South Carolina
483 Huber Soda, LLC (DBA Natrium Products)Dec 6, 2024 · Cortland, New York
483 Arzol Chemical CompanyJun 14, 2024 · Keene, New Hampshire
483 Syntho Pharmaceuticals Inc.Mar 1, 2024 · Farmingdale, New York
483 AgroChem USA, LLCJan 13, 2023 · Saratoga Springs, New York
483 Pharbest Pharmaceuticals, IncNov 10, 2022 · Farmingdale, New York

About this profile

What does Tanya R. Syffrard inspect?

Tanya R. Syffrard appears on 11 documents on file covering 11 sites, mostly in New York.

What do they cite most often?

21 CFR 211.166 (stability testing), followed by 21 CFR 211.42 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Tanya R. Syffrard is dated Mar 28, 2025.